MoneyWorks4Me

Dr. Reddys Laboratories informs about company updates

01 Feb 2020 Evaluate

Dr. Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended December 31, 2019, with the United States Securities and Exchange Commission on January 31, 2020. A copy of the Form 6-K is attached. The Form 6-K is also available on the Company’s website, www.drreddys.com. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..